MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dyskinesias"

  • 2017 International Congress

    Is there a significant relationship between weight loss and prevalence of side effects of Parkinsonian medication? A retrospective, single-centre analysis, South Wales, UK.

    B. Schroeder, E. Thomas, T. Williams, S. Mahon, B. Mohamed (Cardiff, United Kingdom)

    Objective: To investigate if there is a significant relationship between weight loss in persons with Parkinson’s disease and side-effect incidence, and if so to what…
  • 2017 International Congress

    Tremor as the first symptom reported by Parkinson’s disease patients is a predictor of future motor subtype and levodopa-induced dyskinesia.

    A. Schumacher-Schuh, F. Drumond, J. Leal, M. Dotto, S. Machado, C. Rieder (Porto Alegre, Brazil)

    Objective: To better delineate risk profiles for the development of levodopa-induced dyskinesia is an important effort that can help understand this phenomenon and could impact…
  • 2017 International Congress

    Tremor-Dominant Clinical Phenotype is Associated with Low Risk of Levodopa-Induced Dyskinesia in Parkinson’s Disease

    B. Santos-Lobato, M. Capelari, N. Novaretti, Â. Vieira, V. Borges, H. Ferraz, I. Mata, C. Zabetian, V. Tumas (Ribeirão Preto, Brazil)

    Objective:  To evaluate possible associations between epidemiological and clinical data with risk of levodopa-induced dyskinesias (LID) onset in  Parkinson’s disease (PD) patients. Background: LID are…
  • 2017 International Congress

    Wearable sensor-based therapy titration for Parkinson’s Disease

    R. Schmidt, D. Heldman, A. Hadley, D. Riley (Cleveland, OH, USA)

    Objective: To describe a home-based method for improved Parkinson’s therapy titration. Background: Many patients with Parkinson’s disease, due to the location of their residence or…
  • 2017 International Congress

    Association of Single Nucleotide Polymorphism in MAOB and Risk of Levodopa-Induced Dyskinesias in Parkinson’s Disease

    B. Santos-Lobato, M. Capelari, N. Novaretti, Â. Vieira, V. Borges, H. Ferraz, I. Mata, C. Zabetian, V. Tumas (Ribeirão Preto, Brazil)

    Objective: To identify genetic risk factors for developing levodopa-induced dyskinesias (LID) in patients with Parkinson’s disease (PD). Background: LID are common complications in PD, but…
  • 2017 International Congress

    Cause-Specific Hazard of Motor and Nonmotor Long Term Complications of Idiopathic Parkinson’s Disease in a Hospital-based Outpatient Clinic Incident Cohort of 1333 Patients

    S. Prange, C. Laurencin, t. danaila, m.-b. delphine, S. Thobois (bron, France)

    Objective: To compare the relative incidence rates, at identical disease duration, of motor and nonmotor clinical milestones in the long-term disease course of Parkinson’s disease…
  • 2017 International Congress

    Final validation of an electronic diary for motor fluctuations and dyskinesias evaluation in PD patients: Comparison with paperback diary.

    C. Terroba, A. Medina, F. Nanni, V. Bruno, D. Cerquetti, M. Rossi, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the reliability and compliance to an electronic motor diary in PD patients.  Background: Despite paper diaries are widely used, adherence, duplication, fraudulent…
  • 2017 International Congress

    Genetic variants influencing dyskinesia; potential consequences for treatment in Parkinson’s disease

    C. Kusters, K. Paul, I. Guella, J. Bronstein, J. Sinsheimer, M. Farrer, B. Ritz (Los Angeles, CA, USA)

    Objective: To examine the association between dyskinesia and haplotypes in the genes of three dopamine receptors (DRD1, DRD2 and DRD3) and of the Brain Derived…
  • 2017 International Congress

    Levodopa induced dyskinesia in a case of progressive supranuclear palsy.

    T. Yamamoto, H. Kawasaki, T. Furuya, A. Miyake, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, K. Takahashi, N. Tamura, N. Araki (Saitama, Japan)

    Objective: We describe the mechanism of dyskinesia in patients with progressive supranuclear palsy (PSP). Background: Levodopa generally shows a poor effect to parkinsonism in patients…
  • 2017 International Congress

    Personal KinetiGraph (PKG) for Parkinson’s Disease: Experience at a Tertiary Care Center

    V. Sharma, A. Fowler, K. Lyons, R. Pahwa (Kansas City, KS, USA)

    Objective: To assess objective measurements by Personal KinetiGraph (PKG) in Parkinson’s disease (PD) patients and compare them to self-reported symptoms.   Background: Personal Kinetigraph (PKG)…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 40
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley